Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
-------- Â
13:52
--------
13:52
High-Concentration Cannabinoids: Are They Safe?
Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.
-------- Â
29:05
--------
29:05
What You May Have Missed in 2024: Part 1
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
-------- Â
20:13
--------
20:13
Fibrillation - When Ablation is the Way to Go
Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.
-------- Â
22:36
--------
22:36
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.
South Africa